PFE Pfizer Inc

Price (delayed)

$53.58

Market cap

$300.74B

P/E Ratio

15.67

Dividend/share

$1.56

EPS

$3.42

Enterprise value

$338.65B

Pfizer Inc. is an American multinational pharmaceutical corporation. It is one of the world's largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United ...

Highlights
Pfizer's net income has surged by 140% YoY and by 53% QoQ
Pfizer's EPS has soared by 139% YoY and by 53% from the previous quarter
The gross margin has contracted by 20% YoY and by 9% from the previous quarter

Key stats

What are the main financial stats of PFE
Market
Shares outstanding
5.61B
Market cap
$300.74B
Enterprise value
$338.65B
Valuations
Price to earnings (P/E)
15.67
Price to book (P/B)
3.97
Price to sales (P/S)
4.73
EV/EBIT
16.76
EV/EBITDA
13.46
EV/Sales
5.32
Earnings
Revenue
$63.6B
EBIT
$20.21B
EBITDA
$25.17B
Free cash flow
$29.29B
Per share
EPS
$3.42
Free cash flow per share
$5.22
Book value per share
$13.5
Revenue per share
$11.34
TBVPS
$18.43
Balance sheet
Total assets
$179.19B
Total liabilities
$103.22B
Debt
$39.88B
Equity
$75.69B
Working capital
$16.1B
Liquidity
Debt to equity
0.53
Current ratio
1.39
Quick ratio
0.99
Net debt/EBITDA
1.51
Margins
EBITDA margin
39.6%
Gross margin
64.3%
Net margin
30.2%
Operating margin
27.7%
Efficiency
Return on assets
11.6%
Return on equity
27.6%
Return on invested capital
21.6%
Return on capital employed
14.7%
Return on sales
31.8%
Dividend
Dividend yield
2.91%
DPS
$1.56
Payout ratio
45.6%

PFE stock price

How has the Pfizer stock price performed over time
Intraday
1.08%
1 week
-0.87%
1 month
-9.49%
1 year
47.85%
YTD
-9.26%
QTD
-9.26%

Financial performance

How have Pfizer's revenue and profit performed over time
Revenue
$63.6B
Gross profit
$40.86B
Operating income
$17.61B
Net income
$19.18B
Gross margin
64.3%
Net margin
30.2%
Pfizer's net income has surged by 140% YoY and by 53% QoQ
Pfizer's revenue has surged by 97% YoY and by 28% QoQ
The operating income has soared by 70% from the previous quarter
Pfizer's gross profit has soared by 58% YoY and by 17% from the previous quarter

Growth

What is Pfizer's growth rate over time

Valuation

What is Pfizer stock price valuation
P/E
15.67
P/B
3.97
P/S
4.73
EV/EBIT
16.76
EV/EBITDA
13.46
EV/Sales
5.32
Pfizer's EPS has soared by 139% YoY and by 53% from the previous quarter
The price to earnings (P/E) is 13% lower than the last 4 quarters average of 17.8 and 9% lower than the 5-year quarterly average of 17.1
PFE's P/B is 27% above its last 4 quarters average of 3.1 and 19% above its 5-year quarterly average of 3.3
Pfizer's equity has increased by 16% YoY and by 8% QoQ
Pfizer's revenue has surged by 97% YoY and by 28% QoQ
PFE's P/S is 4% above its last 4 quarters average of 4.5 but 2.5% below its 5-year quarterly average of 4.8

Efficiency

How efficient is Pfizer business performance
Pfizer's ROA has soared by 152% YoY and by 53% from the previous quarter
The ROE has soared by 123% YoY and by 48% QoQ
Pfizer's ROS has soared by 59% YoY and by 17% from the previous quarter
The company's return on invested capital has surged by 55% QoQ

Dividends

What is PFE's dividend history
DPS
$1.56
Dividend yield
2.91%
Payout ratio
45.6%
Recent dividends

Financial health

How did Pfizer financials performed over time
PFE's total assets is 74% greater than its total liabilities
The quick ratio has grown by 9% from the previous quarter and by 6% YoY
The company's total liabilities fell by 9% YoY but it rose by 3.6% QoQ
PFE's debt is 47% less than its equity
The debt to equity has contracted by 45% YoY and by 5% from the previous quarter
PFE's debt is down by 37% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.